At what gestational age should the nuchal fold thickness be measured?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nuchal Fold Measurement Timing

The nuchal fold should be measured between 15 and 20 weeks of gestation, with a threshold of ≥6 mm defining an abnormally thickened nuchal fold during this gestational age window 1.

Key Technical Details

Measurement Window

  • Primary measurement window: 15-20 weeks gestation 1
  • The measurement can be extended through 24 weeks, though the standardized threshold of 6 mm was specifically validated for the 15-20 week period 1

Measurement Technique

The nuchal fold is measured in the transverse plane of the fetal head, angled caudally to capture:

  • The cerebellum
  • The occipital bone
  • Calipers placed between the outer edge of the skin and outer edge of the occipital bone 1

Diagnostic Threshold

  • ≥6 mm is considered thickened between 15-20 weeks 1
  • This represents one of the most specific ultrasound markers for trisomy 21, with a positive likelihood ratio of 11-23 when associated with other findings, or 3.8 when isolated 1

Important Distinction: Nuchal Fold vs. Nuchal Translucency

Do not confuse nuchal fold with nuchal translucency:

  • Nuchal translucency: First trimester measurement (11-14 weeks) 2
  • Nuchal fold: Second trimester measurement (15-20 weeks) 1

These are distinct measurements performed at different gestational ages with different clinical implications.

Gestational Age Considerations

Research evidence suggests nuchal fold thickness increases with advancing gestational age 3, 4, 5, 6, 7, 8:

  • At 16 weeks: mean approximately 3.1-3.7 mm 4, 5
  • At 20 weeks: mean approximately 4.5-5.0 mm 4, 5
  • At 24 weeks: mean approximately 5.1 mm, with 95th percentile remaining <6 mm 5

However, the SMFM guideline maintains the single threshold of ≥6 mm for the entire 15-20 week window 1, which simplifies clinical application and has been validated for trisomy 21 detection.

Clinical Pitfall

Some older research 6 suggested using differential thresholds (5 mm for 14-18 weeks, 6 mm for 19-24 weeks), but current SMFM guidelines standardize the threshold at 6 mm for 15-20 weeks 1. This unified approach reduces confusion and maintains high specificity for aneuploidy detection.

References

Research

Reference values of nuchal fold thickness in an Iranian population sample.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2018

Research

Fetal nuchal fold thickness measurement between 18 and 24 weeks of pregnancy: reference intervals for a Brazilian population.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2015

Research

Impact of gestational age on nuchal fold thickness in the second trimester.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2014

Research

Nomogram of nuchal fold thickness of Thai fetuses.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1998

Research

Fetal nuchal skin-fold thickness during the 2nd trimester of pregnancy.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.